about
sameAs
Photoaffinity labeling of plasma proteinsDifferential effects of methoxy group on the interaction of curcuminoids with two major ligand binding sites of human serum albuminFunctional analysis of recombinant human serum albumin domains for pharmaceutical applications.Biological characteristics of two lysines on human serum albumin in the high-affinity binding of 4Z,15Z-bilirubin-IXα revealed by phage display.Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.Nanoscale Diblock copolymer micelles: characterizations and estimation of the effective diffusion coefficients of biomolecules release through cylindrical diffusion model.Pleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung InjuryStereoselective binding of human serum albumin.Pharmaceutically important pre- and posttranslational modifications on human serum albumin.Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases.Pharmaceutical aspects of the recombinant human serum albumin dimer: structural characteristics, biological properties, and medical applications.Levoleucovorin as replacement for leucovorin in cancer treatment.Redox properties of serum albumin.Albumin-drug interaction and its clinical implication.S-Nitrosated human serum albumin dimer as novel nano-EPR enhancer applied to macromolecular anti-tumor drugs such as micelles and liposomes.Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin.Renoprotective effect of long acting thioredoxin by modulating oxidative stress and macrophage migration inhibitory factor against rhabdomyolysis-associated acute kidney injury.Therapeutic impact of human serum albumin-thioredoxin fusion protein on influenza virus-induced lung injury mice.Albumin fusion of thioredoxin--the production and evaluation of its biological activity for potential therapeutic applications.Flunitrazepam, a 7-nitro-1,4-benzodiazepine that is unable to bind to the indole-benzodiazepine site of human serum albumin.How do fatty acids cause allosteric binding of drugs to human serum albumin?Albumin fusion renders thioredoxin an effective anti-oxidative and anti-inflammatory agent for preventing cisplatin-induced nephrotoxicity.Use of photoaffinity labeling and site-directed mutagenesis for identification of the key residue responsible for extraordinarily high affinity binding of UCN-01 in human alpha1-acid glycoprotein.Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design.A novel S-sulfhydrated human serum albumin preparation suppresses melanin synthesis.Apoptosis induction of poly-S-nitrosated human serum albumin in resistant solid tumor under hypoxia can be restored by phosphodiesterase 5 inhibition.Quantitative determination of polysulfide in albumins, plasma proteins and biological fluid samples using a novel combined assays approach.Human serum albumin hydropersulfide is a potent reactive oxygen species scavenger in oxidative stress conditions such as chronic kidney disease.Characterization of benzodiazepine binding site on human alpha1-acid glycoprotein using flunitrazepam as a photolabeling agent.Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression.Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nanoantioxidant for treatment of two acute hepatitis models.Subdomain IIIA of dog albumin contains a binding site similar to site II of human albumin.Thioredoxin-albumin fusion protein prevents copper enhanced zinc-induced neurotoxicity via its antioxidative activity.Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions.Design and tuning of a cell-penetrating albumin derivative as a versatile nanovehicle for intracellular drug delivery.Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions.Cross-linked human serum albumin dimer has the potential for use as a plasma-retaining agent for the fatty acid-conjugated antidiabetic drugs.Evaluation of a new type of nano-sized carbon monoxide donor on treating mice with experimentally induced colitis.Benzbromarone Attenuates Oxidative Stress in Angiotensin II- and Salt-Induced Hypertensive Model Rats.
P50
Q26829329-9DDCBC35-0E5C-41C8-AD37-9C8B62288239Q28539455-6A087A10-946C-4362-939B-EC47B745DC3CQ30344308-4785565E-2035-4F6B-9630-ADA9C081C0CFQ34007697-1A00007E-31EF-4106-A2AF-8B2B4CECAA59Q34702948-DEA80EC3-8A8E-4FBB-B1F3-CF89990EB4C4Q35227017-311A9F65-8F77-4CB4-81F4-E09458921D49Q35666900-1CE8A7DA-95D1-45F4-BCA6-7E4029E4EA20Q35666900-DC182A8F-FB4E-42CA-A83D-8664EA3E2329Q36376111-17D0777C-DD65-4CDD-B032-E8DCF3029067Q37428486-66C7DA0E-88D8-4449-BF50-2E66F51DEFC6Q37453196-11C97746-684A-4587-A271-08BCEF7B2645Q38008984-28892C82-B1EC-4CCD-982B-03C4238C69A7Q38049068-973DCB8F-E042-4A70-A78E-F3C87F783A93Q38104197-8533E646-1426-4AAF-B508-467A9E969C73Q38105869-0F4060C7-F5F5-4D50-84FA-7B8F36C7226DQ38841228-A9D1D6C1-CE53-404B-B420-D55CCF6A44FDQ41001222-71B49B75-F7D9-4097-BDE5-36BF154C08BEQ41301610-5CF1FF39-CC58-4A5A-80B6-22B1327DAE5BQ41653544-32177BA0-FEE0-4AB9-83BD-E152E1E0A827Q42949081-FC1E6949-4E1B-4AD7-A18F-7269F710DC6FQ43570161-01CDA84A-F984-4566-9738-FD254F9A65C6Q44211826-629A01B1-E803-48CD-A1B1-7C248735BC6DQ44364979-611ADC88-8B77-40A0-9F08-21C71CD4CE0AQ45127785-BB7E07FC-1F20-4CA8-8B03-335C64CB6759Q46091421-251E920A-E2F1-45CF-A6BF-89546BDD79CCQ46282593-F2A1BF23-493A-4542-AD29-24B7B56B7B86Q46382241-B0EA70C2-4514-490E-8759-150C5F47159DQ46382667-464F9CDC-718E-4AC9-A15E-6180CAAB223BQ46485696-15D02FB3-F3B0-44DF-82A7-781E70412D4EQ46566824-243970D3-B1E4-4DE9-926C-3BBBE7AC2395Q46650069-6BFD1828-D176-4B37-862D-2F44F01C62E6Q46814306-FB7892FE-CC15-4DDA-87DC-A67B4D1F07B0Q46959111-FCA16DA3-15E8-4CD6-92BF-713E1737408EQ47419734-82E7E4FD-9BAD-4A28-9ADF-CFD6851A4F7CQ48741200-820230F4-CF48-4448-BFD0-32C13A71B2BAQ50672553-FBDFFBE3-0125-4A3F-950F-844BE4E0F8D4Q52358669-962FF9B2-330E-4B3A-9936-A97EFBC8090DQ52567489-F0954A71-4929-489B-B79E-6053AB5E2117Q53647034-6EC731E2-B840-4600-80D1-7FC05074DC8DQ54487094-A7F84555-ED69-4C52-8916-84640541E9DF
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Victor Tuan Giam Chuang
@ast
Victor Tuan Giam Chuang
@en
Victor Tuan Giam Chuang
@es
Victor Tuan Giam Chuang
@nl
Victor Tuan Giam Chuang
@sl
type
label
Victor Tuan Giam Chuang
@ast
Victor Tuan Giam Chuang
@en
Victor Tuan Giam Chuang
@es
Victor Tuan Giam Chuang
@nl
Victor Tuan Giam Chuang
@sl
prefLabel
Victor Tuan Giam Chuang
@ast
Victor Tuan Giam Chuang
@en
Victor Tuan Giam Chuang
@es
Victor Tuan Giam Chuang
@nl
Victor Tuan Giam Chuang
@sl
P108
P227
P101
P106
P108
P1153
7006236644
P21
P214
300149414910189550401
P227
1122775180
P31
P496
0000-0002-2141-630X
0000-0003-4543-2256
P735
P7859
lccn-n2017183552